![Patient with hives (chronic spontaneous urticaria [CSU]) -- Image credit: suriya | stock.adobe.com](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/f7c28cd2ba0b3498c4a0de7219e357228265f4ac-5472x3648.jpg?w=400&h=225&fit=crop&q=80&auto=format)
Remibrutinib, an oral BTK inhibitor for chronic spontaneous urticaria (CSU), delivers itch and hive relief within 12 hours and sustains improvements through week 1.
Published: 2/27/2026
Data presented at AAAAI 2026 show tapinarof cream improves sleep for children as young as 2 years with atopic dermatitis, easing nighttime disruption.
Published: 2/27/2026
The FDA issued a drug safety communication regarding rare but severe pruritus associated with discontinuation of long-term use of cetirizine or levocetirizine.
Published: 2/19/2026
FDA approves difamilast (Adquey), a topical PDE4 inhibitor, expanding nonsteroidal options for mild to moderate atopic dermatitis in dermatology patients 2 years and older.
Published: 2/18/2026
The updates allow for patients of reproductive age to complete pregnancy tests at home during or after treatment.
Published: 2/11/2026
Research reveals that patients with asthma who experience symptoms of depression show elevated BDNF levels, suggesting unique biological links between asthma severity and depressive symptoms.
Published: 1/30/2026
New research reveals how specific gut bacteria in infants may reduce the risk of allergies and asthma, offering potential preventive strategies.
Published: 1/26/2026
Rocatinlimab shows promise in treating moderate-to-severe atopic dermatitis, offering significant symptom relief.
Published: 1/22/2026
Research reveals how eczema's timing and severity influence children's chances of outgrowing food allergies, highlighting the connection between skin health and allergy tolerance.
Published: 1/13/2026
The pivotal clinical trial supports the concomitant administration of tirzepatide and ixekizumab, which significantly improves outcomes for patients with psoriatic arthritis (PsA) and obesity.
Published: 1/12/2026
Collaborative health care efforts are needed to effectively manage asthma, and pharmacists play a key role in optimizing asthma treatment plans.
Published: 1/9/2026
Research reveals that wildfire smoke exposure significantly impacts pediatric asthma control in the northeastern US, highlighting urgent climate health concerns.
Published: 12/29/2025
Researchers uncover how type 2 innate lymphoid (ILC2) and T helper 2 (Th2) cells in allergic asthma survive toxic environments, revealing potential new therapeutic strategies for treatment.
Published: 12/22/2025
The FDA approves depemokimab-ulaa as a long-acting treatment for severe asthma, enhancing patient care with fewer injections and improved outcomes.
Published: 12/17/2025
A study reveals that many asthma patients switch biologics due to perceived ineffectiveness, highlighting the need for personalized treatment strategies.
Published: 12/12/2025
Researchers reveal fibroblasts as key players in hidradenitis suppurativa inflammation, paving the way for innovative treatment strategies.
Published: 12/2/2025
The FDA approves Amneal's albuterol sulfate inhalation aerosol, enhancing access to vital asthma and COPD treatments for millions of Americans.
Published: 12/2/2025
Infants hospitalized with respiratory syncytial virus (RSV) bronchiolitis who were born to parents with asthma had a significantly higher risk of later developing asthma, the investigators found.
Published: 12/1/2025